EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Extracellular Vesicles for the Treatment of Alzheimer's Disease: A Systematic Review

Jolene Phelps iD, Amanda Orr iD, Katherine S Elvira iD, Stephanie M Willerth iD

Journal of Extracellular Biology · 2025-08 · 4 (8)

DOI: 10.1002/jex2.70077 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Extracellular Biology, online erschienen am 20.08.2025. Verfasst von Jolene Phelps und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering University of Victoria Victoria BC Canada. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Alzheimer Society Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of novel treatments that restore brain function and improve patient outcomes for Alzheimer's disease (AD) is necessary, given the complications and lack of improvement in recently approved amyloid beta (Aβ)‐targeting drugs. Cell‐derived extracellular vesicles (EVs) have been found to improve cognitive function through reduced inflammation, oxidative stress, and apoptosis, restoring neuronal and blood‐brain barrier function, and inhibiting Aβ and phosphorylated tau build‐up in the brain. Given the recent emergence of EVs into clinical trials, it is essential to provide the field with an update on proposed mechanisms of action, gaps in knowledge for further study, and recommendations for producing EVs with high therapeutic efficacy to ensure success in subsequent clinical trials. This systematic review summarizes original research to date that reports effects of mammalian cell‐derived EVs for the treatment of AD. Evidence of therapeutic benefits and reported mechanisms of action are discussed. Further, methods for engineering EVs to increase their therapeutic efficacy and produce high‐quality EVs relevant to the AD field are outlined. The quality of evidence is discussed in terms of reporting guidelines from the Minimal Information for Studies of Extracellular Vesicles (MISEV). The review further discusses current preclinical AD models and provides direction to improve the quality of AD models for testing novel therapeutics.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseextracellular vesiclesneurodegenerationtherapeutictreatment

Autor:innen und Institutionen

  • Department of Mechanical Engineering University of Victoria Victoria BC Canada.
  • Division of Medical Sciences University of Victoria Victoria BC Canada.
  • Centre for Advanced Materials and Technology University of Victoria Victoria BC Canada.
  • Department of Chemistry University of Victoria Victoria BC Canada.
  • School of Biomedical Engineering University of British Columbia Vancouver BC Canada.

ORCID-Profile: Jolene Phelps, Amanda Orr, Katherine S Elvira, Stephanie M Willerth

Förderung

  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
  • Alzheimer Society Research Program

Zitieren

APA

Phelps, J., Orr, A., Elvira, K. S., & Willerth, S. M. (2025). Extracellular Vesicles for the Treatment of Alzheimer's Disease: A Systematic Review. Journal of Extracellular Biology, 4(8). https://doi.org/10.1002/jex2.70077

Vancouver

Phelps J, Orr A, Elvira KS, Willerth SM. Extracellular Vesicles for the Treatment of Alzheimer's Disease: A Systematic Review. Journal of Extracellular Biology. 2025;4(8). doi:10.1002/jex2.70077

BibTeX
@article{Phelps2025,
  author = {Phelps, Jolene and Orr, Amanda and Elvira, Katherine S and Willerth, Stephanie M},
  title = {Extracellular Vesicles for the Treatment of Alzheimer's Disease: A Systematic Review},
  journal = {Journal of Extracellular Biology},
  year = {2025},
  volume = {4},
  number = {8},
  doi = {10.1002/jex2.70077}
}
Kostenlos starten →